TECRENZIA Trademark

Trademark Overview


On Thursday, September 28, 2023, a trademark application was filed for TECRENZIA with the United States Patent and Trademark Office. The USPTO has given the TECRENZIA trademark a serial number of 79382629. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 21, 2025. This trademark is owned by GB Pharma S.r.l.. The TECRENZIA trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes, namely, for treating cystic fibrosis; eye and medicated compresses; drugs for medical purposes being pharmaceutical preparations for treating cystic fibrosis; medicines for human purposes for treating cystic fibrosis; hormones for medical purposes for treating cystic fibrosis; zinc supplement, medicated, cough, and throat lozenges for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; Chemical preparations for medical purposes for treating cystic fibrosis; pharmaceutical preparations for treating cystic fibrosis; chemico-pharmaceutical preparations for treating cystic fibrosis; pharmaceuticals for treating fibrosis; mineral, sodium, and oral rehydration salts for medical purposes for treating cystic fibrosis; capsules sold empty for medicines
tecrenzia

General Information


Serial Number79382629
Word MarkTECRENZIA
Filing DateThursday, September 28, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2025

Trademark Statements


Goods and ServicesAdjuvants for medical purposes, namely, for treating cystic fibrosis; eye and medicated compresses; drugs for medical purposes being pharmaceutical preparations for treating cystic fibrosis; medicines for human purposes for treating cystic fibrosis; hormones for medical purposes for treating cystic fibrosis; zinc supplement, medicated, cough, and throat lozenges for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; Chemical preparations for medical purposes for treating cystic fibrosis; pharmaceutical preparations for treating cystic fibrosis; chemico-pharmaceutical preparations for treating cystic fibrosis; pharmaceuticals for treating fibrosis; mineral, sodium, and oral rehydration salts for medical purposes for treating cystic fibrosis; capsules sold empty for medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGB Pharma S.r.l.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIT

Party NameGB Pharma S.r.l.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIT

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, November 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 22, 2024NON-FINAL ACTION WRITTEN
Friday, June 7, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 7, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 18, 2024REFUSAL PROCESSED BY MPU
Wednesday, June 19, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 8, 2024REFUSAL PROCESSED BY IB
Tuesday, November 21, 2023APPLICATION FILING RECEIPT MAILED
Monday, May 20, 2024ASSIGNED TO EXAMINER
Tuesday, December 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 18, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED